Frankfurt
27.12.24
08:24 Uhr
1,400 Euro
-0,060
-4,11 %
-4,11 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.11. | Nephros reports Q3 results | 1 | Seeking Alpha | ||
| 24.10. | Nephros, Inc.: Nephros Launches New HydraGuard 20" UltraFilter | 1 | GlobeNewswire (USA) | ||
| NEPHROS Aktie jetzt für 0€ handeln | |||||
| 18.10. | Nephros-Aktie stürzt auf 52-Wochen-Tief von 1,43 US-Dollar | 2 | Investing.com Deutsch | ||
| 18.10. | Nephros stock plunges to 52-week low of $1.43 amid market challenges | 1 | Investing.com | ||
| 17.10. | Nephros, Inc.: Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton | 1 | GlobeNewswire (USA) | ||
| 09.10. | Nephros-Aktie fällt auf 52-Wochen-Tief von 1,45 US-Dollar | - | Investing.com Deutsch | ||
| 09.10. | Nephros stock plunges to 52-week low of $1.45 amid market challenges | 3 | Investing.com | ||
| 26.08. | NEPHROS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08. | Earnings call: Nephros reports mixed Q2 2024 results, focuses on digital tools | 1 | Investing.com | ||
| 08.08. | Nephros, Inc.: Nephros Announces Financial Results for Quarter Ended June 30, 2024 | 157 | GlobeNewswire (Europe) | Second-Quarter Net Revenue of $3.3 Million; New Accounts Help Drive Growth in Core Programmatic Business SOUTH ORANGE, NJ, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading... ► Artikel lesen | |
| 08.08. | NEPHROS INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 01.08. | Nephros, Inc.: Nephros Schedules Second Quarter 2024 Financial Results Conference Call | 2 | GlobeNewswire (USA) | ||
| 07.03. | Nephros, Inc.: Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results | 195 | GlobeNewswire (Europe) | Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Nephros, Inc. (Nasdaq: NEPH), a leading... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,903 | -0,74 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 7,590 | +0,80 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,455 | +1,77 % | Butterfly Network CTO verkauft Aktien im Wert von 10.009 US-Dollar | ||
| CARMAT | 1,030 | -0,96 % | CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt | Buy-back by CARMAT of 2 million shares from Airbus for a symbolic sum of 1 euro. The shares so bought-back will be allocated to the repayment of the Company's financial debt, via their... ► Artikel lesen | |
| JOINT CORP | 9,930 | -2,46 % | JOINT Corp - 8-K, Current Report | ||
| GOODRX | 4,600 | +1,77 % | Raymond James adds UnitedHealth, drops GoodRx from favorites list | ||
| TALKSPACE | 3,150 | -2,17 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| MIMEDX | 9,420 | +0,32 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 81,95 | -1,89 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,869 | -0,52 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| ATRICURE | 30,720 | -0,10 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| BIOMERICA | 0,315 | -2,29 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| PROGYNY | 16,900 | +14,89 % | Progyny (NASDAQ:PGNY) Shares Gap Up After Insider Buying Activity | ||
| PROPHASE LABS | 0,629 | +0,53 % | ProPhase Labs, Inc. - 8-K, Current Report | ||
| AMWELL | 7,770 | +1,11 % | Amwell announces new chief financial officer | BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding... ► Artikel lesen |
Das Unternehmen NEPHROS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -4,11 % bei einem Aktienkurs von 1,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEPHROS INC finden Sie auf Wallstreet Online.
